Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study - Summary - MDSpire

Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

  • By

  • Vincent Levy

  • Mario Jreige

  • Laura Haefliger

  • Celine Du Pasquier

  • Camille Noirot

  • Anna Dorothea Wagner

  • Styliani Mantziari

  • Markus Schäfer

  • Naik Vietti-Violi

  • Clarisse Dromain

  • May 16, 2025

  • 0 min

Share

Objective:

Add mention of the secondary objective.

Key Findings:
  • Add a brief explanation of clinical significance.
Interpretation:

Emphasize implications for clinical practice.

Limitations:
  • Expand on how limitations impact conclusions.
Conclusion:

Reiterate potential impact on patient management.

Original Source(s)

Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

  • by Vincent Levy, Mario Jreige, Laura Haefliger, Celine Du Pasquier, Camille Noirot, Anna Dorothea Wagner, Styliani Mantziari, Markus Schäfer, Naik Vietti-Violi, Clarisse Dromain

  • May 16, 2025

Related Content

Neoadjuvant Radiotherapy with Camrelizumab as a Chemotherapy-Sparing Strategy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Results from a Phase II Trial (ESOCORT-NIRT)

ARTIFICIAL INTELLIGENCE-ASSISTED RADIOTHERAPY FOR PELVIC AND ABDOMINAL MALIGNANCIES: ASSESSING FEASIBILITY IN THE CONTEXT OF AFRICA‑SPECIFIC RISKS

Survival Factors in IDH-Wildtype Glioblastoma: Insights from a Comprehensive Real-World Cohort Study on Clinical, Molecular, and Immunological Aspects Following Radiotherapy